about
The concept of immune surveillance against tumors. The first theoriesThe circadian clock in cancer development and therapyPeto's Paradox: evolution's prescription for cancer preventionImmune suppressive effect of cinnamaldehyde due to inhibition of proliferation and induction of apoptosis in immune cells: implications in cancerThe tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer.Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control study.Age-related oxidative stress compromises endosomal proteostasis.Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patients.Tumor-host signaling interaction reveals a systemic, age-dependent splenic immune influence on tumor development.Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysisThymus: the next (re)generation.Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors.Interactions between immune challenges and cancer cells proliferation: timing does matter!The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters.Mast cell-directed recruitment of MHC class II positive cells and eosinophils towards mesenteric lymphatic vessels in adulthood and elderly.Immunosenescence of human natural killer cells.Local targets for immune therapy to cancer: tumor draining lymph nodes and tumor microenvironment.Immune Checkpoint Inhibitors in Older Adults.Does Regular Exercise Counter T Cell Immunosenescence Reducing the Risk of Developing Cancer and Promoting Successful Treatment of Malignancies?Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy.Cancer and Aging - the Inflammatory Connection.Aging, cancer, and cancer vaccinesImpact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.Prognostic clinical factors associated with remission and relapse in bullous pemphigoid.The ageing immune system and its clinical implicationsCancer surgery in the elderlyReversing the immune ageing clock: lifestyle modifications and pharmacological interventions
P2860
Q28073937-19EED3A1-CAC2-4886-8205-08793717F911Q28390451-0F40C687-FA4A-497C-A33F-A81AA54A003BQ28741797-B7190159-F655-4A5D-A1A4-E739E5F65943Q34278246-6083D8ED-074E-4532-8263-EF83D85C1D05Q35201907-F7FBB2E0-EA3A-413A-AB4C-3FE65171458AQ35880045-99031F30-3743-415A-9E02-23DA800BF9D2Q36128492-676DEBE6-3090-4A3B-B62E-D825FF6E75BFQ36198776-193769DC-995F-47A0-B04E-52F6F23B4E0AQ36546383-9A5316A3-07B7-46C0-BDC5-02016DBA1CC4Q36565659-54451941-E186-48CC-912C-AD9D755054B8Q36815662-F4D7BEDF-9E51-4059-9EF2-A5ACF0F600C1Q37230550-9E27088C-4898-4B46-8456-78C5579C062DQ37304503-BDE0ACE5-7A23-4077-878E-A8AE5380D52DQ37327398-EC641218-8FE3-4A68-BAAF-A214D11BCCE5Q37653928-A07DE999-8274-4FAD-85A8-B999FC859BFBQ37876092-B30DBA19-4E78-4208-AFD1-A20261D09FF4Q38031760-E8B50A35-D379-49FA-8EAE-598B981153F0Q38861565-D1110067-DB6D-4058-AA34-18D4E979410AQ40104771-846D225F-77FE-4DC6-B51D-C5FDD926FBEAQ40282288-3FE1A009-C38C-42D0-82D0-94B081829B91Q41983762-32BD344C-8453-4972-93A1-B59C8C5F4469Q42172986-D5E1FE7A-8710-44CA-AC91-DFB8A260DD25Q42220062-2328AA3F-D852-4C6F-9F1E-504F1B336829Q53065575-342D6E70-D082-474E-BAAC-EB4223CC929DQ58045474-13DF94AB-B863-48DA-AF64-1F231CADC25FQ58914739-4485D5E1-21C8-49A8-BC6A-93E385584B54Q59132180-FE518C57-091D-4EA7-B526-875E3466047F
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Immunosenescence and cancer
@ast
Immunosenescence and cancer
@en
Immunosenescence and cancer
@en-gb
Immunosenescence and cancer
@nl
type
label
Immunosenescence and cancer
@ast
Immunosenescence and cancer
@en
Immunosenescence and cancer
@en-gb
Immunosenescence and cancer
@nl
prefLabel
Immunosenescence and cancer
@ast
Immunosenescence and cancer
@en
Immunosenescence and cancer
@en-gb
Immunosenescence and cancer
@nl
P3181
P1476
Immunosenescence and cancer
@en
P2093
Anis Larbi
P304
P3181
P356
10.1016/J.CRITREVONC.2010.06.012
P407
P577
2010-08-01T00:00:00Z